Pharmaceutical News Headlines for July 31 2012 ( Tuesday )


• FDA Rejects Regeneron Pharmaceuticals, Inc. (REGN)'s Arcalyst for Gout More...

• Arena Pharmaceuticals, Inc. (ARNA) Transfers Diet Pill Application to Eisai Company, Ltd. (ESALY.PK) More...

• FDA Accepts NuPathe Inc. (PATH)'s Migraine Patch NDA Resubmission for Filing More...

• Ariad Pharmaceuticals, Inc. (ARIA) Announces Submission of New Drug Application for Ponatinib to the FDA More...

• Vertex Pharmaceuticals Incorporated (VRTX) Lowers Incivek View; New Drug Data Lifts Shares More...

• Nymox Pharmaceutical (NYMX) Reports Positive Results From Combined Statistical Analysis of Long Term Follow-Up Studies of BPH Drug More...

• Rockwell Medical Technologies (RMTI) Completes Patient Enrollment in Phase III Clinical Trials for SFP Iron-Delivery in Hemodialysis Patients More...

• Pfizer Inc. (PFE) Announces Positive Top-Line Results From the ORAL Start Phase 3 Study of Tofacitinib in Rheumatoid Arthritis More...

• FDA Requests Teleconference to Discuss Repros Therapeutics Inc. (RPRX) Phase 2 Protocol for Proellex® in the Treatment of Endometriosis Last Week of August More...

• Mindreading Hormone? A Better Judge of Character With Nasal Spray? University of Oslo Study More...

• Rejected Alzheimer's Drug Shows New Potential, Mount Sinai School of Medicine Study More...

• Brains are Different in People With Highly Superior Autobiographical Memory,University of California, Irvine Study More...

• Computer Scientists Present Smile Database, University of Amsterdam Study More...

• Brain Development Delayed in ADHD, National Institutes of Health (NIH) Study More...

• StemCells Inc. (STEM) Broadens HuCNS-SC® Patent Portfolio With Key Patent in Japan More...

• GeNO LLC Receives Two Additional Patents For Inhaled Nitric Oxide Drug Delivery More...

• Abon Announces CLOLAR® Patent Challenge More...

• GlaxoSmithKline (GSK) Shipping U.S. Flu Vaccine With New Strain Coverage Recommended for 2012-2013 More...

• Mersana Therapeutics, Inc. Raises $27 Million to Advance Antibody-drug Conjugates More...

• Ultragenyx Raises $15 Million Toward $30 Million Goal More...

• CytomX Therapeutics, Inc. Expands Series B Financing; Canaan PartnersJoins Syndicate More...

• CMC Biologics Acquires XOMA Corporation (XOMA)'s Bay Area Manufacturing Facility More...

• CytoDyn Announces Entry into Agreement With Progenics Pharmaceuticals, Inc. (PGNX) to Acquire PRO 140 More...

• Idenix Pharmaceuticals, Inc. (IDIX) Regains Drug Rights From Partner Novartis AG (NVS) More...

• PolyMedix Inc. (PYMX.OB) and University of Pennsylvania Collaborate to Develop New Class of Defensin-Mimetic Antimicrobial Compounds to Treat Malaria More...

• Furiex Pharmaceuticals, Inc. (FURX) Announces Closing of Priligy® Asset Transfer and License Agreements More...

• Oncobiologics Inc. Announces a Collaboration Agreement with XOMA Corporation (XOMA) to Utilize XOMA's Fully Human Antibody Libraries for Their Discovery Platform More...

• Anchor Therapeutics Enters Into Collaborative Research Agreement With Kyowa Hakko Kirin for its Pepducin Technology More...

• KV Pharmaceutical CEO Gets Hefty Raise, Despite All the Problems More...

• Soren Tulstrup to Lead Shire plc (SHPG) HGT's MPS Franchise More...

• Cytovance Biologics Inc. Announces Don Wuchterl as Senior Vice President of Manufacturing Operations More...

• Quick-Med Technologies (QMDT) Appoints Bernd Liesenfeld as President More...

• A.P. Pharma, Inc. (APPA) Appoints Robert Rosen to Its Board of Directors More...

• Bayer AG (BAY.F) Lifts Guidance, Provisions Weigh on Earnings More...

• Acura Pharmaceuticals, Inc. (ACUR) Announces Second Quarter 2012 Financial Results More...

• Agennix AG Reports Financial Results for Second Quarter and First Half of 2012 More...

• Amarin Corporation PLC (AMRN) to Report Second Quarter 2012 Financial Results and Host Conference Call on August 8, 2012 More...

• Acasti Pharma First Quarter Results More...

• Teva Pharmaceutical Industries Limited (TEVA) Sues Genzyme Corporation (GENZ) for Poaching Employees More...

• EU Antitrust Charge for Servier, Teva Pharmaceutical Industries Limited (TEVA), Others Over Generics More...

• Immunovative Inc. Announces the Retention of Winston & Strawn LLP as Its Legal Counsel More...

• Vitrolife's Subsidiary in the USA has Been Sued More...

• IntelliPharmaCeutics Settles Patent Litigation With AstraZeneca PLC (AZN) Concerning Generic Seroquel XR® More...

• Theorem Clinical Research Relocates Headquarters to Accommodate Growth More...
Tags: , ,

About author

Make it happen !!

0 comments

Leave a Reply